Fragkoulis C, Bamias A, Gavalas N, Tzannis K, et al. Intravesical Administration of Durvalumab for High-risk Non-muscle-invasive Bladder Cancer: A Phase 2 Study by the Hellenic GU Cancer Group. Eur Urol 2025 Jan 17:S0302-2838(24)02785-4. doi: 10.1016/j.eururo.2024.
PMID: 39827021